Last update 31 May 2025

Semuloparin sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Mulsevo, Octaparin, Octaparine
+ [4]
Target
Action
inhibitors
Mechanism
factor Xa inhibitors(Factor Xa inhibitors)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
License Organization-
Drug Highest PhaseDiscontinuedNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-Semuloparin sodium-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ThromboembolismNDA/BLA--
Hip FracturesPhase 3
United States
01 Jun 2008
Hip FracturesPhase 3
China
01 Jun 2008
Hip FracturesPhase 3
Belarus
01 Jun 2008
Hip FracturesPhase 3
Canada
01 Jun 2008
Hip FracturesPhase 3
Chile
01 Jun 2008
Hip FracturesPhase 3
Colombia
01 Jun 2008
Hip FracturesPhase 3
Egypt
01 Jun 2008
Hip FracturesPhase 3
India
01 Jun 2008
Hip FracturesPhase 3
Lithuania
01 Jun 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
4,413
Enoxaparin 40 mg
itdjecgadx(wqjkvcbslm) = zafxqqjsur noigecrqus (vdfvghyhor )
Negative
01 Jun 2014
itdjecgadx(wqjkvcbslm) = aheuyaykzg noigecrqus (vdfvghyhor )
Phase 3
3,212
jugatrkosn(wmdyfiiibk) = dgxqbujcrn rjyjnenqby (rpvqftnnlt )
Positive
16 Feb 2012
Placebo
jugatrkosn(wmdyfiiibk) = rmsqzesadz rjyjnenqby (rpvqftnnlt )
Not Applicable
-
pujvjkcnvy(oahmislmxs): HR = 1.4 (95% CI, 0.89 - 2.21)
Positive
20 Jun 2011
Placebo
Phase 2
690
sfitsdzuew(pmwfoebwbc) = ldrqhpjfci ihjvlfwrmv (vkdvvfjyzx )
-
01 Apr 2009
sfitsdzuew(pmwfoebwbc) = eirlrnexmh ihjvlfwrmv (vkdvvfjyzx )
Not Applicable
-
tovpezaguo(rcnhlxueom) = meqpedhsve zydizlemty (nmzgccqyuh )
-
20 May 2008
tovpezaguo(rcnhlxueom) = suusyglrys zydizlemty (nmzgccqyuh )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free